- Home
- CIVB vs NMRA Comparison
CIVB vs NMRA Comparison
Compare CIVB & NMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | CIVB | NMRA |
|---|---|---|
| Founded | 1884 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 433.8M | 424.4M |
| IPO Year | N/A | 2023 |
Fundamental Metrics
Financial Performance| Metric | CIVB | NMRA |
|---|---|---|
| Price | $22.29 | $1.84 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 8 |
| Target Price | ★ $25.40 | $8.00 |
| AVG Volume (30 Days) | 126.4K | ★ 982.0K |
| Earning Date | 01-29-2026 | 11-06-2025 |
| Dividend Yield | ★ 3.07% | N/A |
| EPS Growth | ★ 33.31 | N/A |
| EPS | ★ 2.66 | N/A |
| Revenue | ★ $163,095,000.00 | N/A |
| Revenue This Year | $18.06 | N/A |
| Revenue Next Year | $11.12 | N/A |
| P/E Ratio | $8.31 | ★ N/A |
| Revenue Growth | ★ 11.28 | N/A |
| 52 Week Low | $17.47 | $0.61 |
| 52 Week High | $25.59 | $3.25 |
Technical Indicators
Market Signals| Indicator | CIVB | NMRA |
|---|---|---|
| Relative Strength Index (RSI) | 40.52 | 32.42 |
| Support Level | $21.80 | $1.57 |
| Resistance Level | $22.60 | $1.86 |
| Average True Range (ATR) | 0.57 | 0.13 |
| MACD | -0.24 | -0.01 |
| Stochastic Oscillator | 18.49 | 28.02 |
Price Performance
Historical ComparisonAbout CIVB Civista Bancshares Inc.
Civista Bancshares Inc is a financial holding company. Operating through its subsidiary, it engages in the business of community banking. Its business activity involves collecting customer deposits, making loans, purchasing securities, and offering trust services to its clients. The company's loan portfolio includes commercial and agriculture, commercial real estate-owner occupied, commercial real estate non-owner occupied, residential real estate, real estate construction, and consumer loans. Majority of its revenues are derived from the interest and fees gained on loans.
About NMRA Neumora Therapeutics Inc.
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.